Final answer:
A national competitive advantage in the pharmaceutical industry means that a country has unique strengths or resources that give its pharmaceutical companies an edge over competitors in other countries.
Step-by-step explanation:
A national competitive advantage in the pharmaceutical industry means that the country has unique strengths or resources that give its pharmaceutical companies an edge over competitors in other countries. This advantage can be the result of various factors, such as government support for scientific research, strong programs to invest in research and development, a legal environment that protects inventors, or a natural endowment that enables the production of certain medicines.
For example, a country with abundant natural resources may have an absolute advantage in producing medicines that require those resources. Similarly, a country that invests heavily in scientific research and development may have a competitive advantage in discovering and developing new drugs.
In the case of United Borova Laboratories Inc., the national competitive advantage implies that the company benefits from favorable conditions, resources, or support within the country, allowing it to outperform competitors and maintain a strong position in the pharmaceutical industry.